Loading organizations...
Key people at i&i Biotech Fund.
Key people at i&i Biotech Fund.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 3, 2026 | Antiverse | $9.3M Series A | Michal Sikyta | Rhian Elston, DOMiNO Ventures, Lynda Stoelker, Kadmos Capital |
| Dec 17, 2025 | T-Curx | $20.0M Curx - Series A | Dr. Aristotelis Nastos | Monika Steger |
| Nov 19, 2025 | Captain T Cell | $23.2M Other Equity | PD Dr. med. Theis Terwey, Andreas Schmidt | Brandenburg Kapital, Hil-Invent, Barbora Šumová, Sintra Limited, Technologiegründerfonds Sachsen |
| Oct 1, 2024 | Antiverse | $5.0M Seed | Jaromir Zahradka, John Gebeily | G20 Ventures, Innospark Ventures, AngelHub, Tensor Ventures, UKI2S |
| May 22, 2024 | Captain T Cell | $9.2M Seed | — | Nam Nguyen, Germany, Friedrich Hillebrand, Jaromir Zahradka |
| Nov 2, 2022 | Enzyre | $11.9M Series A | Pieter Rhemrev | Demcon Investment, Karel Kubias, Novalis Biotech, Takeda Ventures |
| Ternary Therapeutics | $5.0M Ternary Therapeutics Seed Round | Daphni, Cristian Pinto | Pace Ventures, Oliver Sexton |